Additional endovascular therapy in patients with acute ischemic stroke who are nonresponsive to intravenous tissue plasminogen activator: Usefulness of magnetic resonance angiography-diffusion mismatch

Journal of Stroke and Cerebrovascular Diseases

Volumn 22, Issue 7, 2013, Pages 1056-1063

  Dembo, Tomohisa ^a   Deguchi, Ichiro ^a   Fukuoka, Takuya ^a   Nagoya, Harumitsu ^a   Maruyama, Hajime ^a   Kato, Yuji ^a   Horiuchi, Yohsuke ^a   Ohe, Yasuko ^a   Tanahashi, Norio ^a  

^a SAITAMA MEDICAL UNIVERSITY INTERNATIONAL MEDICAL CENTER   (Japan)

Author keywords

Acute ischemic stroke; endovascular therapy; magnetic resonance angiography diffusion weighted imaging mismatch; tissue plasminogen activator

Indexed keywords

ALTEPLASE; NORPHENAZONE;

ADULT; AGED; ARTICLE; ASPIRATION CATHETER; BALLOON CATHETER; BRAIN ANGIOGRAPHY; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONTRAST MEDIUM EXTRAVASATION; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; ENDOVASCULAR SURGERY; FEMALE; FIBRINOLYTIC THERAPY; GUIDING CATHETER; HUMAN; INCIDENCE; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE ANGIOGRAPHY DIFFUSION WEIGHTED IMAGING MISMATCH; MAJOR CLINICAL STUDY; MALE; MECHANICAL CLOT DISRUPTION; MICROCATHETER; OUTCOME ASSESSMENT; PATIENT SELECTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RADIOLOGICAL PARAMETERS; RANKIN SCALE; RECANALIZATION; SINGLE DRUG DOSE; THROMBUS ASPIRATION; TREATMENT RESPONSE;

ACUTE ISCHEMIC STROKE; ENDOVASCULAR THERAPY; MAGNETIC RESONANCE ANGIOGRAPHY-DIFFUSION-WEIGHTED IMAGING MISMATCH; TISSUE PLASMINOGEN ACTIVATOR;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; DIFFUSION MAGNETIC RESONANCE IMAGING; ENDOVASCULAR PROCEDURES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; RETREATMENT; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84886035591     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2012.07.002     Document Type: Article

References (26)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group Tissue plasminogen activator for acute ischemic stroke N Engl J Med 333 1995 1581 1597
2. W. Hacke, M. Kaste, and E. Bluhmki Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke N Engl J Med 359 2008 1317 1329
3. R. Bhatia, M.D. Hill, and N. Shobha Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke. Real-world experience and a call for action Stroke 41 2010 2254 2258
4. M. Saqqur, K. Uchino, and A.M. Demchuk Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke Stroke 38 2007 948 954
5. G.J. del Zoppo, K. Poeck, and M.S. Pessin Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke Ann Neurol 32 1992 78 86
6. M. Rubiera, M. Ribo, and J. Pagola Bridging intravenous-intra-arterial rescue strategy increases recanalization and the likelihood of a good outcome in nonresponder intravenous tissue plasminogen activator-treated patients. A case-control study Stroke 42 2011 993 997
7. T. Kawakami, Y. Terakawa, and T. Tsuruno Mechanical clot disruption following intravenous recombinant tissue plasminogen activator administration in non-responders Neurol Med Chir (Tokyo) 50 2010 183 191
8. K. Morita, T. Sorimachi, and T. Jinbo Combined treatment of intravenous recombinant tissue plasminogen activator and intra-arterial thrombolysis for ultra-acute ischemic stroke J Neuroendovasc Ther 4 2010 78 83
9. J.T. Kim, W. Yoon, and M.S. Park Early outcome of combined thrombolysis based on the mismatch on perfusion CT Cerebrovasc Dis 28 2009 259 265
10. A.I. Qureshi, N. Janjua, and J.F. Kirmani Mechanical disruption of thrombus following intravenous tissue plasminogen activator for ischemic stroke J Neuroimaging 17 2007 124 130
11. H.S. Shaltoni, K.C. Albright, and N.R. Gonzales Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke? Stroke 38 2007 80 84
12. M.D. Hill, P.A. Barer, and A.M. Demchuk Acute intravenous-intra-arterial revascularization therapy for severe ischemic stroke Stroke 33 2002 279 282
13. T. Hirano, M. Sasaki, and E. Mori Residual vessel length on magnetic resonance angiograpy identifies poor responders to alteplase in acute middle cerebral artery occlusion patients. Exploratory analysis of the Japan Alteplase Clinical Trial II Stroke 41 2010 2828 2833
14. K. Kimura, Y. Iguchi, and K. Shibazaki Large ischemic lesions on diffusion-weighted imaging done before intravenous tissue plasminogen activator thrombolysis predicts a poor outcome in patients with acute stroke Stroke 39 2008 2388 2391
15. T. Fukuoka, T. Dembo, and H. Nagoya Three cases of middle cerebral artery occlusion emergently revascularized with a balloon expandable coronary bare stent after intravenous tissue plasminogen activator J Stroke Cerebrovasc Dis 21 2012 883 889
16. F.H. Sheehan, E. Braunwald, and P. Canner The effect of intravenous thrombolytic therapy on left ventricular function: A report on tissue-type plasminogen activator and streptokinase from the thrombolysis in myocardial infarction (TIMI phase I) trial Circulation 75 1987 817 829
17. W. Hacke, M. Kaste, and C. Fieschi Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooprative Acute Stroke Study (ECASS) JAMA 274 1995 1017 1025
18. N. Wahlgren, N. Ahmed, and A. Davalos Thrombolysis with alteplase for acute ischemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): An observation study Lancet 369 2007 275 282
19. H.L. Lutsep, M.M. Rymer, and G.M. Nesbit Vertebrobasilar revascularization rates and outcomes in the MERCI and multi-MERCI trials J Stroke Cerebrovasc Dis 17 2008 55 57
20. I. Deguchi, H. Takeda, and D. Furuya Significance of magnetic resonance angiograpy-diffusion weighted imaging mismatch in hyperacute cerebral infarction J Stroke Cerebrovasc Dis 21 2012 108 113
21. K. Yagi, K.T. Kitazato, and M. Uno Edaravone, a free radical scavenger, inhibits MMP-9-related brain hemorrhage in rats treated with tissue plasminogen activator Stroke 40 2009 626 631
22. T. Yamashita, T. Kamiya, and K. Deguchi Dissociation and protection of the neurovascular unit after thrombolysis and reperfusion in ischemic rat brain J Cereb Blood Flow Metab 29 2009 715 725
23. G.W. Albers, V.N. Thijs, and L. Wechsler Magnetic resonance imaging profiles predict clinical response to early reperfusion: The Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) Study Ann Neurol 60 2006 508 517
24. W. Hacke, G. Albers, and Y. AI-Rawi The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase Stroke 36 2005 66 73
25. A.J. Furlan, D. Eyding, and G.W. Albers Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): Evidence of safety and efficacy 3 to 9 hours after stroke onset Stroke 37 2006 1227 1231
26. I. Deguchi, T. Dembo, and T. Fukuoka Magnetic resonance angiography-diffusion mismatch reflects diffusion-perfusion mismatch in patients with hyperacute cerebral infarction J Stroke Cerebrovasc Dis 22 2012 334 339